Format

Send to

Choose Destination
Eur J Cardiothorac Surg. 2014 Aug;46(2):179-85. doi: 10.1093/ejcts/ezu020. Epub 2014 Feb 25.

Development of ventricular assist devices in China: present status, opportunities and challenges.

Author information

1
School of Life Science and BioEngineering, Beijing University of Technology, Beijing, China.
2
School of Life Science and BioEngineering, Beijing University of Technology, Beijing, China changyu@bjut.edu.cn.
3
Department of Cardiac Surgery, Peking University Third Hospital, Beijing, China.
4
School of Life Science and BioEngineering, Beijing University of Technology, Beijing, China Institut de Cardiologie, Hôpital de la Pitié, Université de Paris, Paris, France.

Abstract

The growing number of heart failure patients and the scarcity of organ donors account for the huge need for the development of mechanical circulatory systems, including ventricular assist devices (VADs) and artificial hearts, in China. Several research programmes on blood pumps have been under way for the last three decades. However, unlike in other countries, the development of VADs has been extremely slow, and no system is currently approved and available for clinical application. There are many reasons for this situation. This article provides an overview of the present development of experimental and clinical research on VADs in China. In addition, the challenges for the clinical development of mechanical circulatory support in China are discussed.

KEYWORDS:

Axial pump; Centrifugal pump; Intra-aorta pump; Ventricular assist devices

PMID:
24569055
DOI:
10.1093/ejcts/ezu020
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center